These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34436508)

  • 1. An immunogenetic view of COVID-19.
    Aguiar VRC; Augusto DG; Castelli EC; Hollenbach JA; Meyer D; Nunes K; Petzl-Erler ML
    Genet Mol Biol; 2021; 44(1 Suppl 1):e20210036. PubMed ID: 34436508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Immunogenetics in COVID-19.
    Pojero F; Candore G; Caruso C; Di Bona D; Groneberg DA; Ligotti ME; Accardi G; Aiello A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenetics of COVID-19.
    Srivastava A; Hollenbach JA
    Immunogenetics; 2023 Jun; 75(3):309-320. PubMed ID: 36534127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness.
    Yazdanparast S; Bakhtiyaridovvombaygi M; Mikanik F; Ahmadi R; Ghorbani M; Mansoorian MR; Mansoorian M; Chegni H; Moshari J; Gharehbaghian A
    Life Sci; 2023 Sep; 328():121907. PubMed ID: 37394094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the immune interactions underlying HLA class I disease associations.
    Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
    Elife; 2020 Apr; 9():. PubMed ID: 32238263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.
    Grolmusz VK; Bozsik A; Papp J; Patócs A
    Front Immunol; 2021; 12():653489. PubMed ID: 33763088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
    Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
    Front Genet; 2022; 13():845474. PubMed ID: 35273641
    [No Abstract]   [Full Text] [Related]  

  • 11. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
    Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
    Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
    Fitzmaurice K; Hurst J; Dring M; Rauch A; McLaren PJ; Günthard HF; Gardiner C; Klenerman P; ;
    Gut; 2015 May; 64(5):813-9. PubMed ID: 24996883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.
    Wang Y; Wu M; Li Y; Yuen HH; He ML
    J Biomed Sci; 2022 May; 29(1):27. PubMed ID: 35505345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
    Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N
    Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering innate immune responses in SARS-CoV-2 infection and COVID-19.
    Diamond MS; Lambris JD; Ting JP; Tsang JS
    Nat Rev Immunol; 2022 Aug; 22(8):465-470. PubMed ID: 35788185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil.
    Pacheco V; Cuber Guimarães R; Corrêa-Moreira D; Magalhães CE; Figueiredo D; Guttmann P; Trindade GF; da Silva JFA; Ano Bom APD; de Lourdes Maia M; Melgaço JG; da Costa Barros TA; da Silva AMV; Group C; Oliveira MME
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Immunogenetics of Aging': report on the activities of the 15th International HLA and Immunogenetics Working Group and 15th International HLA and Immunogenetics Workshop.
    Naumova E; Ivanova M; Pawelec G; Constantinescu I; Bogunia-Kubik K; Lange A; Qguz F; Carin M; Franceschi C; Caruso C; Middleton D
    Tissue Antigens; 2011 Mar; 77(3):187-92. PubMed ID: 21299522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children.
    Lima R; Gootkind EF; De la Flor D; Yockey LJ; Bordt EA; D'Avino P; Ning S; Heath K; Harding K; Zois J; Park G; Hardcastle M; Grinke KA; Grimmel S; Davidson SP; Forde PJ; Hall KE; Neilan AM; Matute JD; Lerou PH; Fasano A; Shui JE; Edlow AG; Yonker LM
    BMC Med Res Methodol; 2020 Sep; 20(1):228. PubMed ID: 32917141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).
    Sokolowska M; Lukasik ZM; Agache I; Akdis CA; Akdis D; Akdis M; Barcik W; Brough HA; Eiwegger T; Eljaszewicz A; Eyerich S; Feleszko W; Gomez-Casado C; Hoffmann-Sommergruber K; Janda J; Jiménez-Saiz R; Jutel M; Knol EF; Kortekaas Krohn I; Kothari A; Makowska J; Moniuszko M; Morita H; O'Mahony L; Nadeau K; Ozdemir C; Pali-Schöll I; Palomares O; Papaleo F; Prunicki M; Schmidt-Weber CB; Sediva A; Schwarze J; Shamji MH; Tramper-Stranders GA; van de Veen W; Untersmayr E
    Allergy; 2020 Oct; 75(10):2445-2476. PubMed ID: 32584441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.